Robeco Institutional Asset Management B.V. Takes $687,000 Position in Teleflex Incorporated (NYSE:TFX)

Robeco Institutional Asset Management B.V. acquired a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 2,779 shares of the medical technology company's stock, valued at approximately $687,000.

A number of other institutional investors also recently modified their holdings of the stock. Janus Henderson Group PLC lifted its holdings in shares of Teleflex by 12.0% in the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company's stock worth $1,223,424,000 after purchasing an additional 581,312 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Teleflex by 564.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company's stock worth $65,304,000 after acquiring an additional 263,743 shares during the last quarter. Cooke & Bieler LP lifted its position in Teleflex by 23.3% in the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company's stock valued at $191,989,000 after acquiring an additional 172,335 shares in the last quarter. Ceredex Value Advisors LLC bought a new stake in Teleflex during the 2nd quarter worth approximately $25,550,000. Finally, National Bank of Canada FI raised its stake in shares of Teleflex by 1,008.2% in the second quarter. National Bank of Canada FI now owns 115,343 shares of the medical technology company's stock worth $24,388,000 after purchasing an additional 104,935 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Insider Activity

In other news, Director Stuart A. Randle sold 2,674 shares of Teleflex stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the transaction, the director now owns 5,496 shares of the company's stock, valued at $1,313,159.28. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.43% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on TFX. Truist Financial reiterated a "hold" rating and set a $227.00 price target (down previously from $255.00) on shares of Teleflex in a report on Monday, November 4th. Mizuho dropped their price target on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, November 1st. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research report on Friday, November 1st. Stephens lifted their target price on shares of Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada reduced their target price on Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $259.25.

Teleflex Trading Up 1.3 %

NYSE:TFX traded up $2.52 during trading hours on Monday, reaching $198.07. The company's stock had a trading volume of 501,972 shares, compared to its average volume of 377,551. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a market capitalization of $9.20 billion, a price-to-earnings ratio of 39.51, a PEG ratio of 2.00 and a beta of 1.18. The firm has a 50-day simple moving average of $235.39 and a 200-day simple moving average of $223.87. Teleflex Incorporated has a 1 year low of $194.58 and a 1 year high of $257.85.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm's revenue was up 2.4% compared to the same quarter last year. During the same period in the prior year, the business posted $3.64 EPS. Research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's payout ratio is presently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.